临床表现 临床表现
Sterre C M de Boer1, Chiara Fenoglio2,3, Andrea Arighi4
1Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
患有行为变异前性痴呆症的女性表现出较高的神经丝光 (NfL) 和状纤维酸蛋白 (GFAP) 水平. 这表明女性可能会出现更先进的疾病,独立于认知储备.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 神经退行性疾病 神经退行性疾病
背景情况:
- 在零星行为变体前性痴呆症 (s-bvFTD) 中,越来越多地认识到与性别相关的差异.
- 患有bvFTD的女性比男性大脑缩,尽管临床严重程度相似.
- 大脑缩与神经退行症标志物如NfL和GFAP相关.
研究的目的:
- 为了研究血清神经丝光 (NfL) 和状纤维酸蛋白 (GFAP) 在s-bvFTD中的水平的性别差异.
- 确定这些生物标志物差异是否与认知储备有关.
- 探索疾病表现和进展的潜在影响.
主要方法:
- 在357名参与者 (275名s-bvFTD,82名PPD) 中使用Simoa测量了血清NfL和GFAP水平.
- 生物标志物水平在性别之间进行了比较,并使用线性回归分析.
- 认知储备在s-bvFTD参与者的子集中使用残余方法进行了评估.
主要成果:
- 患有s-bvFTD的女性的NFL和GFAP水平明显高于男性 (p <0.05).
- 在初级精神疾病 (PPD) 组中没有观察到生物标志物的性别差异.
- 与女性相比,NfL预测男性的认知能力下降更为急剧,独立于认知储备.
结论:
- 患有s-bvFTD的女性表现出明显更高的NfL和GFAP水平,这表明疾病表现的潜在差异.
- 这些生物标志物的性别差异并不能通过认知储备的变化来解释.
- 研究结果表明,患有s-bvFTD的女性可能在更晚期的疾病阶段出现.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


